한빛사논문, 상위피인용논문
Abstract
Dong Chul Lee,1 Hyun Ahm Sohn,1 Zee-Yong Park,5 Sangho Oh,3 Yun Kyung Kang,6 Kyoung-min Lee,5 Minho Kang,1 Ye Jin Jang,1 Suk-Jin Yang,1 Young Ki Hong,1 Hanmi Noh,1,7 Jung-Ae Kim,1,7 Dong Joon Kim,1 Kwang-Hee Bae,4,7 Dong Min Kim,1 Sang J. Chung,1 Hyang Sook Yoo,1 Dae-Yeul Yu,1 Kyung Chan Park,1,* and Young Il Yeom1,2,7,*
1Medical Genomics Research Center
2Ochang Branch Institute
3Korean Bioinformation Center
4Research Center for Integrative Cellulomics
Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 305-806, Korea
5Department of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea
6Department of Pathology, Inje University Seoul Paik Hospital, Seoul 100-032, Korea
7Department of Functional Genomics, Korea University of Science and Technology, Daejeon 305-350, Korea
*Correspondence: yung Chan Park, Young Il Yeom
Summary
Organisms must be able to respond to low oxygen in a number of homeostatic and pathological contexts. Regulation of hypoxic responses via the hypoxia-inducible factor (HIF) is well established, but evidence indicates that other, HIF-independent mechanisms are also involved. Here, we report a hypoxic response that depends on the accumulation of lactate, a metabolite whose production increases in hypoxic conditions. We find that the NDRG3 protein is degraded in a PHD2/VHL-dependent manner in normoxia but is protected from destruction by binding to lactate that accumulates under hypoxia. The stabilized NDRG3 protein binds c-Raf to mediate hypoxia-induced activation of Raf-ERK pathway, promoting angiogenesis and cell growth. Inhibiting cellular lactate production abolishes the NDRG3-mediated hypoxia responses. Our study, therefore, elucidates the molecular basis for lactate-induced hypoxia signaling, which can be exploited for the development of therapies targeting hypoxia-induced diseases.
논문정보
관련 링크
연구자 키워드
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기